a developer of technology and therapeutics for rare diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, ARCT has been loosely correlated with ABCL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ARCT jumps, then ABCL could also see price increases.
Ticker / NAME | Correlation To ARCT | 1D Price Change % | ||
---|---|---|---|---|
ARCT | 100% | -2.04% | ||
ABCL - ARCT | 50% Loosely correlated | -1.35% | ||
CRSP - ARCT | 47% Loosely correlated | -1.85% | ||
BMEA - ARCT | 46% Loosely correlated | -11.42% | ||
PGEN - ARCT | 45% Loosely correlated | -3.57% | ||
BEAM - ARCT | 45% Loosely correlated | -1.57% | ||
More |
Ticker / NAME | Correlation To ARCT | 1D Price Change % |
---|---|---|
ARCT | 100% | -2.04% |
pharmaceuticals theme (159 stocks) | 41% Loosely correlated | -1.94% |
therapeutics theme (53 stocks) | 39% Loosely correlated | -2.44% |